2021 annual financial data
Chemomab Therapeutics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -12,367,000 USD and net income was -12,478,000 USD.
Operating cash flow was -12,382,563 USD.
Get free Chemomab Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -12,367,000 USD
- Net income
- -12,478,000 USD
- Operating cash flow
- -12,382,563 USD